Apollo Endosurgery (APEN) gains 1.01% on Moderate Volume
Apollo Endosurgery Inc (NASDAQ: APEN), a San Diego, California, company, gained to close at $9.01 Friday after gaining $0.09 (1.01%) on volume of 280,657 shares. The stock ranged from a high of $9.05 to a low…
From the Equity Insider archive. This article dates from Oct 26, 2021 and is preserved as first published.
Apollo Endosurgery Inc (NASDAQ: APEN), a San Diego, California, company, gained to close at $9.01 Friday after gaining $0.09 (1.01%) on volume of 280,657 shares. The stock ranged from a high of $9.05 to a low of $8.65 while Apollo Endosurgery’s market cap now stands at $258,613,742.
About Apollo Endosurgery Inc
Apollo Endosurgery Inc (NASDAQ: APEN), a San Diego, California, company, gained to close at $9.
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo’s device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo’s products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
